NL-OMON21085尚未招募不适用
ext generation sequencing in patients with pancreatic ductal adenocarcinoma (PAN-NGS). A nationwide prospective, translational cohort study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- Erasmus MC
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Cytological or histologically confirmed PDAC, irrespective of treatment status;
- •Age > 18 years and = 60 years at date of primary diagnosis;
- •Performance status of ECOG 0-2;
- •Estimated life expectancy of at least 12 weeks;
- •Written informed consent.
排除标准
- •Unwilling to know if there are any alterations which might be associated with genetic predisposition of cancer;
- •Patient with locally-advanced PDAC or local-recurrence of PDAC with no histological tissue available for NGS.
研究者
相似试验
招募中
不适用
ext generation sequencing in patients with pancreatic ductal adenocarcinoma (PAN-NGS). A nationwide prospective, translational cohort study.pancreatic ductal adenocarcinoma10015674pancreatic cancerNL-OMON51960Erasmus MC, Universitair Medisch Centrum Rotterdam300
未知
不适用
Genomic biomarker research for advanced pancreatic cancer and neuroendocrine tumor.JPRN-UMIN000022960Chiba Cancer Center230
已完成
不适用
Study for genetic susceptibility to pancreatic cancerpancreatic cancerJPRN-UMIN000016984Center for Clinical and Biomedical Research, Sapporo Higashi Tokushukai Hospital100
终止
1 期
Investigation of gemcitabine combined with temsirolimus, in patients with inoperable or metastatic pancreatic cancer. A phase I-II study by the Hellenic Cooperative Oncology Group with biomarker evaluation (HE3/07)Patients with inoperable or metastatic pancreatic cancerCancer - PancreaticACTRN12611000643976Hellenic Cooperative Oncology Group85
尚未招募
不适用
Follow up of patients of Indeterminate for chronic pancreatitis for 1 yearCTRI/2019/08/020632Arun Vaidya